Browse by category

At the recent IFSO-EC meeting in Malaga, Spain, Medtronic hosted a fascinating lunch time symposium tiled, ‘A new era in robotic vessel sealing’ featured several presentations and a panel discussion on Medtronic's Ligasure vessel sealing technology, covering its technical underpinnings, clinical applications and recent integration into the Hugo RAS robotic surgery platform. Hugo RAS Ligasure Maryland In the first presentation by Dr Bruce Dunne, Senior Distinguished Engineer,

GT Metabolic Solutions has received CE certification (CE Mark) under the EU Medical Device Regulation (EU MDR) that enables commercialisation of the GT Metabolic Magnet System across the European Economic Area (EEA). GT Metabolic achieved successful review and certification of the GT Metabolic Magnet System for side-to-side enteroenterostomy (40mm, 50mm Magnets; throughout the small bowel) and gastroenterostomy (60mm, 70mm Magnets; stomach to small bowel), the first integrate

Metabolic and bariatric surgery (MBS) for teens with severe obesity is cost-effective over ten years, according to an analysis from Ann & Robert H Lurie Children's Hospital of Chicago, IL. While long-term clinical benefits of weight-loss surgery for eligible teens have been well established, and it is recommended by the American Academy of Pediatrics, insurance coverage has been limited and few teens can take advantage of the surgery. This study strengthens the case for insur

A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of multiple organs. These PET-derived insights into organ-level responses to surgery could support more precise treatment monitoring and personalized metabolic care, according to a study, ‘Evaluation of organic metabolic profiling alternation assessed by [18F]FDG PET/CT in obese patients before and after bariatric surgery’, presented at the Society of Nu

Results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes, have revealed that people with severe obesity on the highest dose (12mg) lost on average 30% of their body weight over two years. In addition, at 80 weeks, all doses of retatrutide (4mg, 9mg and 12mg) met the primary and key secondary endpoints for obesity, delivering clinicall

The ForePass endoscopic metabolic bypass platform reproduced insulin sensitivity levels observed following biliopancreatic diversion (BPD) while substantially outperforming semaglutide (Ozempic/Wegovy) in weight control in a randomised preclinical study, according to a study led by Professor Ivo Boskoski, Professor of Digestive Endoscopy at Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Lazio, Italy. ForePass endoscopic metabolic bypass platform

Bariatric News spoke with Professor Paulina Salminen, a professor of surgery and gastrointestinal surgery at University of Turku and Turku University Hospital in Finland, and President of the European Chapter of the International Federation For Surgery and Other Therapies for Obesity (IFSO-EC/IFSO), about her career path, her commitment to evidence-based research, and the challenges facing metabolic and bariatric surgery (MBS)... Why did you decide to enter medicine? Initial

Both metabolic and bariatric surgery (MBS) and glucagon-like peptide-1 receptor agonist (GLP-1RA) medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk, according to a study by researchers from the Mayo Clinic. Importantly, researchers say the findings are not about choosing one treatment over another, but about better aligning treatment decisions with long-term healt

In this exclusive interview, Professor Luis Ocaña (Hospital Universitario Virgen de la Victoria de Málaga, Spain), IFSO-EC Malaga 2026 Congress President, discusses some of the key highlights at this year’s meeting with a particular focus on the Pre-Congress Courses, the importance medication and surgery, collaboration with SECO (Spanish Society of Bariatric Surgery) and, of course, the sights and sounds of the beautiful city of Malaga... “We have been working with huge enthu

Researchers in France have identified a significant shift in the country towards more complex and potentially more morbid types of revisional metabolic bariatric surgeries (RMBS), underscoring the need of careful patient selection through preoperative assessment and personalised postoperative management to reduce risks and optimise outcomes in this population. The aim of their observational study was to assess the rate of RMBS in France and to outline the associated complicati